A Study on the Safety, Tolerability and Pharmacokinetics of WS-0101 Tablets in Chinese Healthy Subjects
Phase 1
Completed
- Conditions
- Healthy Adult Subjects
- First Posted Date
- 2025-03-04
- Last Posted Date
- 2025-03-04
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 27
- Registration Number
- NCT06857799
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
The Development and Validation of MRI-AI-based Predictive Models for CsPCa
Recruiting
- Conditions
- Prostate Cancer
- First Posted Date
- 2025-02-24
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 3000
- Registration Number
- NCT06842264
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, China
The Factors Affecting IPP in Peritoneal Dialysis Patients with Polycystic Kidney Disease
- Conditions
- Peritoneal DialysisPolycystic Kidney Diseases
- First Posted Date
- 2025-02-24
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06841224
- Locations
- 🇨🇳
Peking university First hospital, Beijing, Beijing, China
Optimizing Prostate Biopsy Schemes in Men With Multiple mpMRI Visible Lesions
Not Applicable
Recruiting
- Conditions
- Prostate Cancer
- First Posted Date
- 2025-02-24
- Last Posted Date
- 2025-02-25
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT06841211
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
Effects of Aromatherapy with Essential Oils on Anxiety and Depression in Perioperative Patients with Pancreatic Cancer
Not Applicable
Not yet recruiting
- Conditions
- Pancreatic Carcinoma
- First Posted Date
- 2025-02-19
- Last Posted Date
- 2025-02-19
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 156
- Registration Number
- NCT06833658
Rivastigmine Mini-Tablet for Alzheimer's Disease
Not yet recruiting
- Conditions
- Alzheimer's Disease
- Interventions
- Drug: Rivastigmine Mini-Tablet
- First Posted Date
- 2025-02-14
- Last Posted Date
- 2025-02-20
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 1000
- Registration Number
- NCT06828289
Impact of Pharmacy Services on Gynaecology Chemotherapy Safety
Completed
- Conditions
- NeoplasmsGynaecological Oncology
- First Posted Date
- 2025-02-14
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 629
- Registration Number
- NCT06826950
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
The Value of Dual-parametric Magnetic Resonance Combined with Regional Saturation Biopsy in Patients with Suspected Prostate Cancer
Not Applicable
Not yet recruiting
- Conditions
- Prostate Cancer
- First Posted Date
- 2025-02-13
- Last Posted Date
- 2025-02-13
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT06824259
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
HEFTME System for Adjuvant Therapeutic Selection of Locally Advanced UTUC Postoperatively：A Perspective Cohort Study
Not yet recruiting
- Conditions
- Upper Tract Urothelial Carcinoma
- Interventions
- First Posted Date
- 2025-01-29
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT06798246
Diagnosis and Allergen Identification of Perioperative Anaphylaxis
Recruiting
- Conditions
- Perioperative/Postoperative ComplicationsAnaphylaxisTryptaseAllergensSkin Testing
- First Posted Date
- 2025-01-27
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 115
- Registration Number
- NCT06793163
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, Beijing, China